Search

Home > GRACEcast Lung Cancer Video > Clinical Trial Spotlight: Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance
Podcast: GRACEcast Lung Cancer Video
Episode:

Clinical Trial Spotlight: Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance
Category: Science & Medicine
Duration: 00:03:24
Publish Date: 2015-11-20 14:00:00
Description:

Dr. Jack West reviews treatment options for patients with an EGFR activating mutation and acquired resistance but no T790M mutation, focusing on a clinical trial with the novel hypoxia-induced pan-HER inhibitor TH4000.
Total Play: 0